NCT04339673

Brief Summary

The aim of the present study was to compare the efficacy of three different treatment methods in the management of myofascial pain: masseteric nerve block (MN), trigger point injection(TrP) with local anesthetic (LA) and dry needling (DN).Study Design: 45 subjects aged 18-54 years were randomly assigned to the MN group (n= 15), LA group (n=15) and DN group (n=15).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2019

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 2, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 9, 2020

Completed
Last Updated

April 9, 2020

Status Verified

April 1, 2020

Enrollment Period

5 months

First QC Date

April 2, 2020

Last Update Submit

April 6, 2020

Conditions

Keywords

paininjectionsanesthetics

Outcome Measures

Primary Outcomes (4)

  • The Rate of Pain on Function (PoF) assessed by Numerical pain Scale (NRS)

    Patients rated their pain on function (pain during chewing or speaking etc.) on a Numeric Rating Scale (NRS) (0-10 where 0 is no pain and 10 is the worst pain imaginable)

    before the injections (T0, Baseline)

  • The Rate of Pain on Function (PoF) assessed by Numerical pain Scale (NRS)

    Patients rated their pain on function (pain during chewing or speaking etc.) on a Numeric Rating Scale (NRS) (0-10 where 0 is no pain and 10 is the worst pain imaginable)

    At 1st week (t1)

  • The Rate of Pain on Function (PoF) assessed by Numerical pain Scale (NRS)

    Patients rated their pain on function (pain during chewing or speaking etc.) on a Numeric Rating Scale (NRS) (0-10 where 0 is no pain and 10 is the worst pain imaginable)

    At 4th week (t2)

  • The Rate of Pain on Function (PoF) assessed by Numerical pain Scale (NRS)

    Patients rated their pain on function (pain during chewing or speaking etc.) on a Numeric Rating Scale (NRS) (0-10 where 0 is no pain and 10 is the worst pain imaginable)

    At 12th week (t3)

Secondary Outcomes (8)

  • The Rate of Pain Intensity on Palpation (PoP)

    before the injections (T0, Baseline)

  • The Rate of Pain Intensity on Palpation (PoP)

    At 1st week (t1)

  • The Rate of Pain Intensity on Palpation (PoP)

    At 4th week (t2)

  • The Rate of Pain Intensity on Palpation (PoP)

    At 12th week (t3)

  • The measurement of pain-free maximum mouth opening (MMO) in millimeters

    before the injections (T0, Baseline)

  • +3 more secondary outcomes

Study Arms (3)

MNB- masseteric nerve block

ACTIVE COMPARATOR

masseteric nerve block with local anesthesia lidocaine single app.

Procedure: masseteric nerve block

LA -trigger point injection with local anesthetic

ACTIVE COMPARATOR

local anesthetic injections on trigger points in masseter

Procedure: trigger point injection

DN-dry needling

PLACEBO COMPARATOR

dren needling to masseter

Procedure: dry needling

Interventions

regional bloc of masseter

MNB- masseteric nerve block

trigger point injection with local anesthetic

LA -trigger point injection with local anesthetic
dry needlingPROCEDURE

needling with acupuncture needles of trigger points in masseter

DN-dry needling

Eligibility Criteria

Age18 Years - 54 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Clinical diagnosis of myofascial pain.
  • Presence of at least one trigger point in masseter muscle.

You may not qualify if:

  • Generalized muscle disorders.
  • Hypersensitivity to local anesthetics.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Erzincan Ağiz Ve Diş Sağlığı Egt Araş Hastanesi

Erzincan, Turkey (Türkiye)

Location

Related Publications (2)

  • Venancio Rde A, Alencar FG Jr, Zamperini C. Botulinum toxin, lidocaine, and dry-needling injections in patients with myofascial pain and headaches. Cranio. 2009 Jan;27(1):46-53. doi: 10.1179/crn.2009.008.

    PMID: 19241799BACKGROUND
  • Quek SY, Subramanian G, Patel J, Ananthan S, Zagury JG, Khan J. Efficacy of regional nerve block in management of myofascial pain of masseteric origin. Cranio. 2015 Oct;33(4):285-90. doi: 10.1080/08869634.2015.1097300. Epub 2015 Dec 29.

MeSH Terms

Conditions

Temporomandibular Joint DisordersMyofascial Pain SyndromesPain

Interventions

Dry Needling

Condition Hierarchy (Ancestors)

Craniomandibular DisordersMandibular DiseasesJaw DiseasesMusculoskeletal DiseasesJoint DiseasesMuscular DiseasesStomatognathic DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsPhysical Therapy Modalities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: randomized parallel controlled
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Dept. Oral and Maxillofacial Surgery

Study Record Dates

First Submitted

April 2, 2020

First Posted

April 9, 2020

Study Start

July 1, 2019

Primary Completion

November 30, 2019

Study Completion

November 30, 2019

Last Updated

April 9, 2020

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will not share

Locations